Home Work Commercial development Market Development
PREVENT and Newcastle Disease & East Coast Fever (PLSHL I & II)

The PREVENT Initiative

Overview

The PREVENT project (PRomoting and Enabling Vaccination Efficiently, Now and Tomorrow), was a 4-year initiative (2021 – 2025) that aimed to establish an innovative and pragmatic veterinary health platform in Africa through medium-size hatchery vaccination.

Improvement in poultry production is one of the most promising options to provide affordable protein and other essential nutrients to Africa’s rapidly growing population. To date, deficient effectiveness of poultry vaccination and lack of information about circulating infectious diseases, have been an issue to small-scale producers in Africa. The PREVENT project, by working with over 36 medium-sized hatcheries spread across eleven African countries, enabled the hatcheries to provide high-quality, vaccinated day-old chicks to small-scale livestock producers (SSPs) together with practical advice and guidance from a team of field technicians. These actions resulted into improved flock health, expansion of flock sizes and ultimately a transformation in the lives of SSPs economically.

PREVENT was an initiative in collaboration with Ceva Santé Animale (Ceva).

 

Achievements

  • More than 215 million vaccinated chicks over the life of the project.
  • Nearly 581 million vaccine doses administered since 2021.
  • More than 200 field technicians trained, and several technical mentorships established strengthening hatchery performance and field-level vaccination practices.

 

 

Videos

PREVENT: Improving Poultry Production in sub-Saharan Africa

The PREVENT project 

Empowering Women in Africa with poultry

Mkuza Chicks in Tanzania Partners with PREVENT

 

Watch more videos here.

 

Newcastle Disease & East Coast Fever (PLSHL I & II)

Under the Protecting Livestock Saving Human Lives I & II programmes (PLSHL, 2008-2017), GALVmed and partners conducted mainly small-scale pilot initiatives in market development designed to deliver certain products, predominantly Newcastle Disease (ND) vaccine for poultry, and East Coast Fever (ECF) vaccine for cattle to small-scale producers in several African and South Asian countries. Having demonstrated economic viability of these field projects, larger market initiatives were developed with global and regional private sector manufacturers, distributors, small and medium enterprises and start-ups to achieve and sustain scale.

Achievements

  • 7 million cattle vaccinated against East Coast Fever
  • 170 million Newcastle Disease vaccines sold
  • Over 2.5 million households reached
  • 10 products delivered and 8 commercialised
  • USD 167 million estimated value of livestock disease mortalities averted
  • Over 12,400 vaccinators trained